Amoxycillin & Potassium Clavulanic Injection IP – Moxival CL 1.2 Injection

Moxival CL 1.2 Injection
Composition:- Amoxycillin 1000mg+Clavulanic Acid

Moxival CL 1.2 Injection – The dual composition of Amoxycillin & Potassium Clavulanic Injection IP is a fixed-dose combination of Amoxicillin and Clavulanic acid designed to treat bacterial infections caused by beta-lactamase-producing organisms.
Amoxicillin disrupts bacterial cell wall synthesis, while Clavulanic acid inhibits beta-lactamase enzymes, preventing antibiotic degradation and extending the antimicrobial spectrum.

Key Points of Amoxycillin & Potassium Clavulanic Injection IP – Moxival CL 1.2 Injection

• Broad-Spectrum Coverage with Beta-Lactamase Protection – Combines Amoxicillin’s bactericidal activity with Clavulanic acid’s enzyme inhibition for enhanced effectiveness against resistant strains.
• Daily Dosing for Patient Compliance – To improving patient adherence without comprising therapeutic efficacy which help to maintains steady blood flow throughout the body.
• Clinical Efficacy with Good Tolerability – Proven therapeutic success with excellent absorption and gastrointestinal tolerance in both outpatient and hospital settings.

Can be Prescribed by:

• General Physician
• Pulmonologist
• Urologist
• Healthcare practitioner

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.